Gafchromic Film for Patient-Specific Quality Assurance in Radiotherapy

Patient-specific quality assurance sits at the heart of safe radiotherapy delivery. Every IMRT, VMAT, or stereotactic plan that leaves a treatment planning system should be checked against a measured standard before it reaches a patient. In Australian centres from Royal North Shore in Sydney to the Peter MacCallum Cancer Centre in Melbourne, physicists have built robust QA programmes around this simple principle: trust, but verify.

Gafchromic film has become one of the most versatile tools in that verification toolkit. The radiochromic medium self-develops without chemical processing, offers near tissue-equivalent response across the megavoltage range, and resolves dose features down to fractions of a millimetre. Several papers presented at the 2014 COMP Annual Scientific Meeting in Banff explored the film as a reference standard against which diode arrays, ion chamber matrices, and log-file reconstructions could be compared.

For delegates planning the trip to the Canadian Rockies, the banquet evening on the final night offered a relaxed setting to swap notes with colleagues from Australia, New Zealand, and across North America about how each centre approaches film-based QA.

Why Patient-Specific QA Still Matters in Modern Radiotherapy

Treatment complexity has grown faster than the QA workflows designed to support it. A single arc delivery on a modern linac can deposit dose through hundreds of small apertures, modulated across gantry rotation, with dynamic MLC motion shaping every degree of arc. Catching a single monitor unit calculation error or a leaf position calibration drift requires a detector that can see the entire dose plane in one exposure.

Film does exactly that. Where a single ion chamber can only sample a point and an array averages over its detector spacing, a sheet of EBT3 captures the full two-dimensional dose distribution in a single measurement. That capability has kept film relevant even as electronic portal imaging devices and independent dose calculation algorithms have matured.

In Australia, ACPSEM has long recommended independent verification of complex plans, and many public hospital networks use film as the second-line check after their primary array measurement. ARPANSA also references patient-specific verification in its Code of Practice for radiation therapy, reinforcing the expectation that every plan receives some form of measured dose confirmation.

What Makes Gafchromic Film a Useful Detector

The self-developing nature of Gafchromic film removes the darkroom step that once limited radiographic film QA. Films can be handled under normal room lighting for short periods and scanned on a flatbed optical densitometer after a recommended development window, typically overnight for EBT3. The active layer polymerises on exposure, producing a colour change whose optical density relates to absorbed dose in a predictable, energy-independent way across the megavoltage spectrum.

Three properties stand out for patient-specific work. First, the spatial resolution is effectively limited by the scanner pixel size, not by detector element spacing, allowing physicists to resolve the steep dose gradients characteristic of stereotactic and dynamic IMRT deliveries. Second, the film is thin and close to water-equivalent, minimising perturbation of the beam and avoiding the volume-averaging artefacts that affect ion chamber arrays. Third, the response is largely independent of dose rate, which matters for FFF beams increasingly common across Australian linac installations.

Different film formulations suit different jobs. EBT3 is the workhorse for general radiotherapy QA, with a useful range from roughly 0.2 Gy to 10 Gy. HD-V2 extends the ceiling for hypofractionated stereotactic treatments where a single fraction may exceed 10 Gy. Choosing the right grade prevents saturation artefacts and keeps optical density measurements within the linear portion of the calibration curve.

A Practical Workflow for Film-Based QA

A reliable film QA workflow rests on three foundations: a current film calibration, consistent handling, and a validated scanning protocol. Calibration sheets should be irradiated on the same linac model that will be used for the patient measurements, at the same energy, with doses traceable to a primary standard. Films should be handled by the edges, marked for orientation, and stored flat in a controlled environment between exposure and scanning.

Scanning introduces its own uncertainty. Warm-up time of the flatbed scanner, orientation of the film on the platen, and resolution choice all influence the result. Many Australian centres scan films in landscape orientation with the active side facing the glass, using a red-green-blue channel analysis to extract the most dose-sensitive component of the colour change. FilmQA Pro, the manufacturer's analysis package, and open-source ImageJ plugins remain the common tools, each with its own quirks around noise correction and lateral scan artefact removal.

The patient measurement itself is usually performed in a solid water or PMMA phantom positioned at a representative depth and SSD. The plan is recalculated onto the phantom CT, delivered, and the resulting film dose map compared against the calculation using gamma analysis with criteria chosen to reflect clinical relevance, commonly 3 percent local dose difference and 2 mm distance-to-agreement for IMRT work, and tighter limits for stereotactic cases.

Common Pitfalls and How Australian Centres Manage Them

Even experienced users encounter a recurring set of pitfalls. Scanner uniformity drifts over time, particularly with consumer-grade Epson units used in many Australian physics departments. A weekly flat-field uniformity check using an unexposed film is a simple safeguard. Polarisation effects, where the film's response depends on the orientation of the polymer chains relative to the scanner, are managed by always loading the film in the same direction.

Batch-to-batch variation can introduce small but measurable calibration shifts. ACPSEM's position paper on radiochromic film recommends cross-calibrating each new box against a reference set, a practice most teaching hospitals in Sydney, Melbourne, and Brisbane have adopted. Edge artefacts from the film cutting process are avoided by leaving at least a 1 cm margin or by using pre-cut sheets supplied in standard sizes.

Films are also sensitive to UV exposure and humidity. Keeping unexposed stock in its original pouches until use, and developing it within a consistent post-exposure window, protects the calibration integrity. Many centres log scanner temperature and humidity at the time of each scan, allowing post-hoc correction if environmental conditions drifted during a measurement session.

Film in Context: Comparing with Arrays and Log Files

Film is not the right tool for every QA job. For routine checks of hundreds of plans per year, the speed and automation of a diode or ion chamber array is hard to beat. For treatments delivered on Varian or Elekta platforms with log-file recording, trajectory log-based reconstruction offers a computational QA path that does not require a phantom measurement at all.

Where film retains a unique role is in cases where spatial resolution and dose gradient mapping matter most. Small-field stereotactic radiosurgery, complex head and neck IMRT with simultaneous integrated boosts, and total marrow irradiation are all areas where the two-dimensional film map reveals dose features that arrays average away. Many Australian centres treat film as the gold standard for these challenging deliveries, while relying on arrays and log files for higher-throughput routine verification.

A complementary approach is gaining traction: use an array or log-file QA as the primary check, and reserve film measurement for a representative subset of plans, or for cases that have failed the first-line check and require independent confirmation. This pragmatic allocation of measurement time keeps QA workloads manageable without abandoning the rigorous verification that complex radiotherapy demands.

Practical Recommendations for a Film QA Programme

• Calibrate each new film batch against a reference set, with doses spanning the clinical range you expect to measure.
• Warm up the flatbed scanner for at least 30 minutes before any QA scan and check uniformity weekly with an unexposed sheet.
• Handle films only by the edges, mark orientation clearly, and store unexposed stock in its original packaging away from direct sunlight.
• Use consistent gamma criteria matched to the treatment complexity, for example 3 percent and 2 mm for standard IMRT, 2 percent and 1 mm for stereotactic deliveries.
• Validate any analysis software against known test patterns and document version numbers used for clinical measurements.
• Maintain a phantom CT library specific to your solid water or PMMA setup so recalculation matches your delivery geometry exactly.
• Keep a record of scanner temperature, humidity, and post-exposure development time with each film measurement to support later audit and troubleshooting.

If your team is reviewing its patient-specific QA practice, consider joining a session at an upcoming professional meeting or reaching out to colleagues who have already refined their film workflow. The archived COMP 2014 programme in Banff remains a useful reference point, and the conference archive site still hosts a range of supplementary content from that year for those interested in the broader delegate experience. Sharing protocols, comparing pitfalls, and benchmarking against other centres is how the Australasian medical physics community continues to lift the standard of radiotherapy verification, one film at a time.